ECA - Quality of Nasal and Inhalation Drug Products
Art-No.: A-1006
Date: 23-25 November 2016
Price: EUR 380,-
The Conference folder includes the following topics:
| No. | Topic | Summary | Pages |
| 12683 | Good Development Practices for Inhalation Drug Products | 0 | 0 |
| 12684 | Development of Modern Nasal Drug Products | 0 | 0 |
| 12685 | Dose Content Uniformity Test | 0 | 33 |
| 12686 | Workshop I: Transfer of Inhalation Specific Methods - DCU and APSD | 0 | 17 |
| 12687 | Particle Size Distribution and Determination | 0 | 44 |
| 12688 | New Testing for Spacer Devices | 0 | 42 |
| 12689 | Requirements for Starting Materials for Inhalation and Nasal Drug Products | 0 | 0 |
| 12690 | Workshop II: Product Characterisation | 0 | 19 |
| 13744 | Nasal and Nebulizer Testing | 0 | 39 |
| 14153 | Requirements for Device and Delivery Systems | 0 | 0 |
| 14154 | Formulation of Biologics for Inhaled and Nasal Drug Products | 0 | 13 |
| 14155 | Regulatory Strategy for the Global Respiratory Market | 0 | 22 |
| 14156 | Extractables/Leachables Assessment for MDI and DPI Devices | 0 | 47 |
| 14157 | Development of Generic and Line Extension Products | 0 | 23 |
| 14158 | Product Characterisation Studies | 0 | 34 |
GMP Conferences by Topics
- Quality Assurance
- GMP in Biotechnology
- Microbiology
- Regulatory Affairs
- GMP in Pharmaceutical Development
- Quality Control
- GDP
- Sterile / Aseptic Manufacturing
- Computer Validation
- Validation
- Technical Operations
- GMP for APIs and Excipients
- Medical Devices
- GMP Basic Training Courses
- Packaging
- Data Integrity